Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme.
Hardy TA, Aouad P, Barnett MH, Blum S, Broadley S, Carroll WM, Crimmins D, Griffiths D, Hodgkinson S, Lechner-Scott J, Lee A, Malhotra R, McCombe P, Parratt J, Plummer C, Van der Walt A, Martel K, Walker RA. Hardy TA, et al. Among authors: carroll wm. Mult Scler J Exp Transl Clin. 2024 Jan 12;10(1):20552173231226106. doi: 10.1177/20552173231226106. eCollection 2024 Jan-Mar. Mult Scler J Exp Transl Clin. 2024. PMID: 38222025 Free PMC article.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, Lechner-Scott J, Scott R, Lea R, Taylor BV, Stankovich J, Butzkueven H, Gresle M, Laws SM, Petrou S, Hoffjan S, Akkad DA, Graham CA, Hawkins S, Glaser A, Bedri SK, Hillert J, Matute C, Antiguedad A; ANZgene Consortium; Wiley JS. Gu BJ, et al. Hum Mol Genet. 2015 Oct 1;24(19):5644-54. doi: 10.1093/hmg/ddv278. Epub 2015 Jul 17. Hum Mol Genet. 2015. PMID: 26188005
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function.
Field J, Shahijanian F, Schibeci S; Australia and New Zealand MS Genetics Consortium (ANZgene); Johnson L, Gresle M, Laverick L, Parnell G, Stewart G, McKay F, Kilpatrick T, Butzkueven H, Booth D. Field J, et al. PLoS One. 2015 Jun 11;10(6):e0127080. doi: 10.1371/journal.pone.0127080. eCollection 2015. PLoS One. 2015. PMID: 26068105 Free PMC article.
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Perrin Ross A, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, Kadner K, Manfrini M, Wang Q, Freedman MS. Hartung HP, et al. Among authors: carroll wm. J Neurol. 2024 Apr 22. doi: 10.1007/s00415-024-12326-z. Online ahead of print. J Neurol. 2024. PMID: 38649522
Future advancement of health care through standardized nursing terminologies: reflections from a Friends of the National Library of Medicine workshop honoring Virginia K. Saba.
Dunn Lopez K, Heermann Langford L, Kennedy R, McCormick K, Delaney CW, Alexander G, Englebright J, Carroll WM, Monsen KA. Dunn Lopez K, et al. Among authors: carroll wm. J Am Med Inform Assoc. 2023 Oct 19;30(11):1878-1884. doi: 10.1093/jamia/ocad156. J Am Med Inform Assoc. 2023. PMID: 37553233
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.
Claflin S, Campbell JA, Norman R, Mason DF, Kalincik T, Simpson-Yap S, Butzkueven H, Carroll WM, Palmer AJ, Blizzard CL, van der Mei I, Henson GJ, Taylor BV. Claflin S, et al. Among authors: carroll wm. Eur J Health Econ. 2023 Aug;24(6):939-950. doi: 10.1007/s10198-022-01518-x. Epub 2022 Sep 23. Eur J Health Econ. 2023. PMID: 36149605 Free PMC article.
162 results